10-07/08 :: July/August 2010
nanotimes
Companies Facts
round. The Atlanta-based company designs and ma- nufactures linear position sensing products for moti- on control manufacturers.
http://www.sentrinsic.com
A S
hrink Nanotechnologies, Inc. (Shrink, OTCBB: INKN) has entered into a technology integrati-
on and development agreement with Lydall, Inc. (NYSE: LDL). Under the terms of the agreement, Lydall will provide Shrink with certain quantities of its Solupore®
thermoplastic membrane for the pur-
pose of conducting a one-year research and develop- ment project. The goal of the project is to develop a robust, ultra-rapid diagnostic platform that increases the sensitivity of fluorescent-based assays by integra- ting Solupore technology with Shrink‘s rapid proto- typing system, ShrinkChip Manufacturing System™ and NanoPetal™ technology. Under the terms of the agreement, any ownership of new intellectual pro- perty will be based on inventorship. Mark L. Baum, CEO of Shrink Nanotechnologies, sta- ted, “This new relationship with Lydall is part of our effort to turn our NanoShrink materials into viable systems used in critical point-of-care and point-of- operations products. The market for these types of sensors is in the billions of US Dollars in annual sales, and they are used in a wide range of commercial applications such as food safety, personalized drug therapies and disease screening, to name a few. By producing more of the overall system solution, with the integration of the Lydall Solupore®
material, we
seek to increase the flexibility and scope of these im- portant diagnostic devices and in turn open the door to future strategic partnerships with leading research laboratories in industry and academia.”
ccording to an SEC filing, Sentrinsic Inc. has closed on $500,018 in an equity financing
Shrink Nanotechnologies announced further the formation a new wholly-owned subsidiary, Shrink Chips LLC, which is dedicated to the commerciali- zation of a suite of next-generation biotechnology research tools, including its patent-pending Shrink- Chip Rapid Prototyping System (RPS) which is used to inexpensively and flexibly manufacture microflui- dic chips, or Lab-on-a-Chip (LOC), devices as well as many other biological and chemical sensors. Shrink announced further that certain patent appli- cations related to its advanced tissue engineering technology platform, CellAlign™, have been filed. CellAlign’s key feature is a micro-fabricated substrate with non-periodic (or random) linear patterned groo- ves that allow for the alignment of cells along a single axis. The unique design is ideal for growing biological tissues from stem cells, especially those that naturally grow in a linear fashion such as in cardiac and nerve tissues.
http://www.lydall.com http://www.shrinknano.com
S S
olazyme, Inc., a renewable oil production company and leader in algal biotechnology, has
raised $52 million in its Series D financing round. Solazyme uses microbial fermentation to produce renewable oil that can be used for clean and scala- ble fuels, chemicals, nutritional food ingredients and health and wellness products.
http://www.solazyme.com
olexant Corp., developer of third-generation ultrathin-film PV technology, announced the
selection of the city of Gresham, Oregon, USA, for the location of its first commercial-scale nanocry- stal manufacturing facility. Upon completion, the
35
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83